Patents by Inventor Michael E. Dunn

Michael E. Dunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12606618
    Abstract: The present disclosure provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the disclosure, the antibodies are fully human antagonist antibodies that bind to NPR1. In some embodiments, the antibodies of the disclosure are useful for blocking NPR1 signaling and/or activity, thus providing a means of treating or preventing a disease, disorder, or condition associated with NPR1, including hypotension, in humans.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: April 21, 2026
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Michael E. Dunn, Lori C. Morton
  • Publication number: 20250333524
    Abstract: The present disclosure provides novel immunoglobulin proteins that bind to a human natriuretic peptide receptor 1 (NPR1) agonist, preferably an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure comprise at least one immunoglobulin variable domain that binds to an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure are useful in blocking and/or reversing the effect of an administered anti-NPR1 antibody. In certain embodiments, the antigen-binding proteins are useful for effective management of blood pressure and hemodynamics in humans.
    Type: Application
    Filed: May 13, 2025
    Publication date: October 30, 2025
    Inventors: Michael E. DUNN, Lori C. MORTON, Neil STAHL, Tammy T. HUANG, Ishita CHATTERJEE, Vishal KAMAT, Ashique RAFIQUE
  • Patent number: 12325752
    Abstract: The present disclosure provides novel immunoglobulin proteins that bind to a human natriuretic peptide receptor 1 (NPR1) agonist, preferably an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure comprise at least one immunoglobulin variable domain that binds to an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure are useful in blocking and/or reversing the effect of an administered anti-NPR1 antibody. In certain embodiments, the antigen-binding proteins are useful for effective management of blood pressure and hemodynamics in humans.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: June 10, 2025
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Michael E. Dunn, Lori C. Morton, Neil Stahl, Tammy T. Huang, Ishita Chatterjee, Vishal Kamat, Ashique Rafique
  • Publication number: 20250034279
    Abstract: The present disclosure is related to methods of reducing blood pressure or effecting a hemodynamic change in a subject, the methods comprising administering to the subject a pharmaceutical composition comprising an agonist of natriuretic peptide receptor 1 (NPR1) (e.g., an agonist anti-NPR1 antibody).
    Type: Application
    Filed: October 11, 2024
    Publication date: January 30, 2025
    Inventors: Michael E. DUNN, Aaron KITHCART, Benjamin Adam OLENCHOCK
  • Publication number: 20240327539
    Abstract: The present disclosure is related to methods of reducing blood pressure or effecting a hemodynamic change in a subject, the methods comprising administering to the subject a pharmaceutical composition comprising an agonist of natriuretic peptide receptor 1 (NPR1) (e.g., an agonist anti-NPR1 antibody).
    Type: Application
    Filed: October 11, 2022
    Publication date: October 3, 2024
    Inventors: Michael E. DUNN, Aaron KITHCART, Benjamin Adam OLENCHOCK
  • Publication number: 20240309103
    Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.
    Type: Application
    Filed: May 31, 2024
    Publication date: September 19, 2024
    Inventors: Michael E. DUNN, Jia SU, Jason MASTAITIS, Jesper GROMADA, Lori C. MORTON
  • Publication number: 20240059780
    Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.
    Type: Application
    Filed: October 11, 2023
    Publication date: February 22, 2024
    Inventors: Michael E. DUNN, Jia SU, Jason MASTAITIS, Jesper GROMADA, Lori C. MORTON
  • Patent number: 11826196
    Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: November 28, 2023
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Sam Cichon, Michael E. Dunn
  • Patent number: 11820826
    Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.
    Type: Grant
    Filed: March 10, 2022
    Date of Patent: November 21, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Michael E. Dunn, Jia Su, Jason Mastaitis, Jesper Gromada, Lori C. Morton
  • Publication number: 20230115770
    Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.
    Type: Application
    Filed: October 17, 2022
    Publication date: April 13, 2023
    Applicant: REGENERON PHARMACEUTICALS, INC.
    Inventors: Sam CICHON, Michael E. DUNN
  • Patent number: 11471124
    Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: October 18, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Sam Cichon, Michael E. Dunn
  • Publication number: 20190328500
    Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.
    Type: Application
    Filed: November 15, 2017
    Publication date: October 31, 2019
    Inventors: Sam CICHON, Michael E. DUNN
  • Publication number: 20190002555
    Abstract: The present invention provides monoclonal antigen-binding proteins that bind to the cardiac glycoside marinobufagenin (MBG), and methods of use. In various embodiments of the invention, the antigen-binding proteins are fully human antigen-binding proteins that bind to MBG. In some embodiments, the antigen-binding proteins of the invention are useful for inhibiting or neutralizing MBG activity, thus providing a means of treating or preventing a MBG-associated disease or disorder selected from the group consisting of hypertension, myocardial fibrosis, uremic cardiomyopathy, heart failure, myocardial infarction, renal failure, renal fibrosis and pre-eclampsia.
    Type: Application
    Filed: July 21, 2016
    Publication date: January 3, 2019
    Applicant: REGENERON PHARMACEUTICALS, INC.
    Inventors: Michael E. DUNN, Lori C. MORTON, Yonaton RAY, Jee H. KIM
  • Patent number: 6945199
    Abstract: The present invention relates to a coolant crossover member and intake manifold assembly adapted for use in a vehicle engine and method for producing the same. The crossover and manifold assembly includes crossover and a manifold. The crossover has a passage formed therein extending between a first end and a second end thereof. The manifold is joined to the first and second ends of the crossover. The manifold is provided with first and second openings which define first and second inner surfaces, respectively.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: September 20, 2005
    Assignee: Hayes Lemmerz International, Inc.
    Inventors: David T. Kapala, Michael E. Dunn, Marcello Tedesco, John S. Frait
  • Patent number: 6250431
    Abstract: A method to retain a minimum running clearance between the friction pads associated with a caliper of a brake and a rotor attached to a wheel of a vehicle. A bearing member associated with the wheel includes a plurality of rollers which axially move about a reference point to allow the rotor to correspondingly move and retract the friction pads of the caliper when the vehicle is subjected to centrifugal forces. This retraction of the friction pads by movement of the rotor creates a minimum running clearance between the rotor and friction pads on termination of the radial forces. A desired running clearance is reestablished during a brake application.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: June 26, 2001
    Assignee: Robert Bosch Corporation
    Inventor: Michael E. Dunn
  • Patent number: 5542503
    Abstract: A rotor adapted for use in a vehicle disc brake assembly includes an inner annular mounting flange portion defining a rotational axis and an outer annular disc portion. The outer annular disc portion includes a pair of friction plates which are connected together in spaced apart relationship by a plurality of posts located about the circumference of the rotor. The plurality of posts are divided into a plurality of groups of four posts. Each group of four posts includes a first post and a second post which are radially aligned with one another along with respect to a first bisecting radius extending outwardly from the rotational axis of the rotor. Each group of four posts also includes a third post and a fourth post which are radially aligned with one another with respect to a second bisecting radius extending outwardly from the rotational axis of the rotor. The first common bisecting radius and the second common bisecting radius are disposed at a predetermined angle relative to one another.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 6, 1996
    Assignee: Kelsey-Hayes Company
    Inventors: Michael E. Dunn, Don Varnelis
  • Patent number: 4008801
    Abstract: A conveyor belt guide comprises a plurality of guide sections, each including an integral polyurethane elongated rib and base web having a width substantially greater than the rib at its juncture with the web. The base web has a fabric backing molded thereon, upon molding of the rib and base web, at the side of the base web opposite the rib. Each section has tapered ends for cooperating with the ends of adjacent sections to prevent guide stripping. The base web has a greater thickness at its juncture to the rib than at its edges, thereby providing a predetermined primary wear area adjacent the rib and a low coefficient of friction between guide section and supporting slide bed. The sections are laid end-to-end into elongated relieved portions of multiple ply conveyor belts so the base web edges are within the belt plane, but the thicker portion of the belt supports the rib above the belt plane.
    Type: Grant
    Filed: June 19, 1975
    Date of Patent: February 22, 1977
    Assignee: F. N. Shepard & Company
    Inventors: James E. Reilly, Frank A. Klaene, Michael E. Dunn